ATOPIC DERMATITIS / ECZEMA

This study tested the safety and effectiveness of tofacitinib, a drug that blocks certain immune signals, for treating skin conditions like eczema and psoriasis in people with Down syndrome. 47 adolescents and adults took part. The goal was to see if the drug could improve these …

This study tested whether a team-based online care model works as well as traditional in-person visits for managing atopic dermatitis (eczema). 300 patients were randomly assigned to either online or in-person care for 12 months. The main goal was to see if eczema severity improv…

This study tested a cream called ARQ-151 in 652 children aged 2 to 5 with eczema. The cream was applied once daily for 4 weeks. The goal was to see if it could clear or nearly clear the skin rash better than a cream with no active ingredient. Results showed that more children usi…

This study looked at the long-term safety of a cream called roflumilast for people with mild to moderate eczema (atopic dermatitis). Over 1,200 participants aged 2 and older applied the cream once daily for up to 52 weeks. The main goal was to track any side effects, and secondar…

This study tested a cream called roflumilast (0.05%) applied once daily for 4 weeks in 101 infants aged 3 months to under 2 years with mild-to-moderate eczema. The main goal was to check safety and side effects, not to measure how well it works. The cream is already used in older…

This study looked at how dupilumab affects the immune and genetic activity inside eczema skin lesions. Seventeen adults with moderate-to-severe eczema received the drug, and researchers measured changes in immune cells and gene activity over 12 weeks. The goal was to understand h…